Camena Bioscience, a Cambridge-based company which provides synthetic genes to the pharmaceutical and biotechnology industries, has completed a £7.8m ($10m) Series A funding round led by Mercia Ventures. The new funding will be used to Read More
London, 3 July 2023 – Gresham House plc (“Gresham House”), the specialist alternative asset manager, has invested a further £50mn into Wildanet Limited (“Wildanet”), Cornwall’s leading alternative broadband network provider, via “BSIF II” (British Sustainable Infrastructure Fund Read More